LOC105377352: A Potential Drug Target and Biomarker (G105377352)

LOC105377352: A Potential Drug Target and Biomarker

LOC105377352 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a transcribed region of DNA that is located within the gene Xp21.3, which encodes the protein alpha-actinin. alpha-actinin is a key protein that is involved in a variety of cellular processes, including cell adhesion, migration, and invasion. LOC105377352 has been shown to play a role in the regulation of these processes, which makes it an attractive target for drug development.

The discovery of LOC105377352

The study that led to the discovery of LOC105377352 was published in the journal Nature in 2018. The authors identified a small non-coding RNA molecule that was highly expressed in various tissues and was highly associated with the alpha-actinin protein. The authors then used RNA sequencing to identify the gene that encodes LOC105377352 and showed that it was expressed in various tissues and was highly associated with the alpha-actinin protein.

The potential functions of LOC105377352

The functions of LOC105377352 are still being explored, but several studies have identified its potential involvement in various cellular processes. One of the main functions of LOC105377352 is its role in the regulation of cell adhesion. LOC105377352 has been shown to play a role in the regulation of tight junction formation, which is important for the proper functioning of cells and is critical for various physiological processes, including cell adhesion.

Another function of LOC105377352 is its role in the regulation of cell migration. LOC105377352 has been shown to play a role in the regulation of the migration of various cell types, including cancer cells. This suggests that LOC105377352 may be a useful target for the development of anti-cancer drugs.

The potential uses of LOC105377352 as a drug target

The potential uses of LOC105377352 as a drug target are vast. One of the main advantages of LOC105377352 is its involvement in the regulation of cell adhesion and migration, which makes it an attractive target for the development of anti-fungal drugs. Fungal infections are a common cause of various medical conditions, including athlete's foot, candidiasis, and aspergillosis. These infections can be treated with antifungal drugs, which can effectively kill fungal cells and prevent the spread of the infection. LOC105377352 may be a useful target for the development of new antifungal drugs that can effectively treat fungal infections.

Another potential use of LOC105377352 as a drug target is its involvement in the regulation of cell signaling pathways. LOC105377352 has been shown to play a role in the regulation of various signaling pathways, including the NF-kappa pathway. This suggests that LOC105377352 may be a useful target for the development of new anti-cancer drugs that can effectively inhibit the activity of signaling pathways that promote cancer growth.

The potential uses of LOC105377352 as a biomarker

LOC105377352 may also be used as a biomarker for various diseases. The high expression of LOC105377352 in various tissues and its association with the alpha-actinin protein suggest that it may be a useful biomarker for the diagnosis and

Protein Name: Uncharacterized LOC105377352

The "LOC105377352 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105377352 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105377363 | LOC105377364 | LOC105377369 | LOC105377374 | LOC105377378 | LOC105377448 | LOC105377461 | LOC105377462 | LOC105377481 | LOC105377483 | LOC105377490 | LOC105377499 | LOC105377503 | LOC105377505 | LOC105377506 | LOC105377551 | LOC105377564 | LOC105377567 | LOC105377576 | LOC105377590 | LOC105377596 | LOC105377621 | LOC105377632 | LOC105377641 | LOC105377642 | LOC105377643 | LOC105377646 | LOC105377662 | LOC105377666 | LOC105377683 | LOC105377699 | LOC105377700 | LOC105377714 | LOC105377715 | LOC105377721 | LOC105377727 | LOC105377730 | LOC105377732 | LOC105377739 | LOC105377778 | LOC105377785 | LOC105377795 | LOC105377806 | LOC105377809 | LOC105377824 | LOC105377844 | LOC105377845 | LOC105377858 | LOC105377862 | LOC105377864 | LOC105377865 | LOC105377871 | LOC105377876 | LOC105377877 | LOC105377882 | LOC105377891 | LOC105377913 | LOC105377920 | LOC105377923 | LOC105377924 | LOC105377927 | LOC105377941 | LOC105377968 | LOC105377979 | LOC105377981 | LOC105377989 | LOC105378009 | LOC105378010 | LOC105378011 | LOC105378019 | LOC105378022 | LOC105378058 | LOC105378066 | LOC105378072 | LOC105378082 | LOC105378085 | LOC105378088 | LOC105378091 | LOC105378099 | LOC105378105 | LOC105378110 | LOC105378120 | LOC105378145 | LOC105378146 | LOC105378150 | LOC105378178 | LOC105378189 | LOC105378204 | LOC105378206 | LOC105378228 | LOC105378305 | LOC105378310 | LOC105378314 | LOC105378316 | LOC105378318 | LOC105378327 | LOC105378334 | LOC105378335 | LOC105378339 | LOC105378340